Skip to content
PG

PROCTER & GAMBLE Co

PROCTER & GAMBLE Co Q1 FY2025 earnings call

October 18, 2024 · fiscal period ended 2024-09

EPS · actual vs est

$1.93 / $1.90Beat +1.6%

Revenue · actual vs est

$21.74B / $21.99BMiss -1.1%
Ask about this call

Summary

Generated 2024-10-18

Management highlights

• Execution of integrated strategy delivered solid earnings and cash results, enabling maintenance of fiscal year '25 guidance ranges. • Organic sales growth driven by volume, pricing, with mix in line. • North America had broad-based market share growth. • Europe focus markets had organic sales growth despite inventory headwinds. • Latin America organic sales up low single digits. • Greater China faced significant declines. • Core earnings per share up 5%, core gross margin in line, core operating margin increased 30 basis points. • Returned nearly $4.4 billion to shareowners. • Continued to push levers to offset headwinds, remain committed to integrated strategy, double-down on superiority, improve productivity, drive constructive disruption, with empowered, agile, accountable organization.

View in transcript ↓

Segment performance

Organic sales grew 2%. Eight of 10 product categories grew or held organic sales for the quarter. Family care, home care and personal healthcare each grew mid-single digits. Hair care, oral care, feminine care, fabric care and grooming grew low singles. Baby care and skin and personal care were down mid-singles. Organic sales in focus markets grew 2% and enterprise markets were up 1%. Organic sales in North America grew 4%, driven by 4 points of volume growth. Europe focus markets organic sales were up 3% with a 2-point headwind from lower inventory. Latin America organic sales were up low single digits. European enterprise markets grew mid-singles. Greater China organic sales declined 15%. Global aggregate value share grew 10 basis points with 28 of our Top 50 category country combinations holding or growing share for the quarter.

View in transcript ↓

Guidance

• Maintains organic sales growth guidance in range of 3% to 5%. • Core EPS guidance range 5% to 7% ($6.91 to $7.05 per share). • Commodity cost headwind after tax approximately $200 million ($0.08 per share). • Foreign exchange in line with prior year. • Lower non-operating income benefits and higher tax rate add $0.10 to $0.12 headwind. • Adjusted free cash flow productivity expected at 90%. • Plans to pay around $10 billion in dividends and repurchase $6 billion to $7 billion in common stock, returning $16 billion to shareowners.

View in transcript ↓

Risks

• Economic and geopolitical environment challenges. • Uncertainty in China and Middle-East markets. • Commodity cost and foreign exchange fluctuations. • Potential geopolitical disruptions, major supply chain disruptions or store closures not anticipated within guidance ranges.

View in transcript ↓

Q&A highlights

Q: Steve Powers asked about the quarter and past 12 months' growth and concerns about deceleration in markets like China and Middle East.

A: Andre Schulten responded that headwinds were expected in front half of fiscal '25, core 85% of business is strong with sustained growth potential and innovation in second half.

Q: Lauren Lieberman asked about risk factor in the 85% of business.

A: Andre Schulten said consumer in daily-use categories continue to trade into P&G and trade up, with data and plans showing confidence in momentum of 85% of business despite China and Middle-East uncertainties.

Q: Dara Mohsenian asked about sustained category growth in US and perspective on 15% of business.

A: Andre Schulten talked about growth opportunities in US categories like fabric enhancers, power oral care, and innovation in Europe, with base assumption of annualizing effects in 15% of business.

Q: Bryan Spillane asked about gross margins and cost of goods sold inflation.

A: Andre Schulten said main driver of gross margin progress is productivity, with some effect from easing inflation but majority to spread throughout year.

Q: Chris Carey asked about baby business and family care business.

A: Andre Schulten said family care business model is sustainable with innovation driving category growth, baby care requires superior propositions for growth despite birth rate dynamics.

Q: Filippo Falorni asked about China recovery pace and progression of organic sales growth.

A: Andre Schulten said predicting China recovery pace is futile, expects sequential improvement due to annualization but range remains, headwinds still present in first two quarters.

Q: Robert Ottenstein asked about structural changes in Chinese market and SK-II brand.

A: Andre Schulten said Chinese consumer behavior is changing, team is adjusting to realities, SK-II brand is relevant but early signs of improvement.

Q: Kevin Grundy asked about market share performance and importance of market shares.

A: Andre Schulten said market share trend is generally positive, focus on growing markets and household penetration, with progress in Europe and US.

Q: Peter Grom asked about China improvement pace and sequential organic sales growth.

A: Andre Schulten said conceptually annualizing headwinds and maintaining run rate in core business needed for guidance range.

Q: Andrea Teixeira asked about skin care performance and confidence in 85% of business.

A: Andre Schulten said guidance is range, 85% of business has sustained track-record of growth with share trajectory upwards and innovation, but multiple scenarios exist.

Q: Kaumil Gajrawala asked about price points, promo, and inventory destocking.

A: Andre Schulten said promo situation stable, no indication of consumer trading down, inventory levels stable.

Q: Mark Astrachan asked about SK-II brand underperformance.

A: Andre Schulten said SK-II brand is relevant with core messaging and efficacy, effects due to Japanese brand in Chinese context, team investing to rebuild equity.

Q: Nik Modi asked about store closures and disruptive innovation.

A: Andre Schulten said no major store closures assumed in US, Olay Melts and Tide evo doing well in test markets with promising progress.

Q: Olivia Tong asked about performance divergence across categories.

A: Andre Schulten said different categories perform differently but global portfolio allows delivery, beauty excluding China and SK-II has growth, fabric and home care has innovation opportunities.

Q: Korinne Wolfmeyer asked about retailer inventory orders and retail dynamic.

A: Andre Schulten said inventory levels stable, retailer relationships constructive, supply chain programs progressing.

Q: Rob Moskow asked about commodity cost benefit and deployment.

A: Andre Schulten said still a $200 million after-tax headwind, business units control offsetting or reinvesting.

Q: Linda Bolton Weiser asked about beauty segment and hair care in China.

A: Andre Schulten said Olay in North America has innovation success, hair care in China has strong innovation with brands like Head & Shoulders and Pantene performing well but market still down.

View in transcript ↓

Key numbers

Reported versus consensus

Earnings calendar feed

MetricReportedConsensusDeltaPrior year
EPS$1.93$1.90+1.6%$1.83
Revenue$21.74B$21.99B-1.1%$21.87B

Transcript

October 18, 2024

Full transcript unavailable for redistribution

The structured summary above covers the available call sections. Full transcript text is not included on this page.

Continue exploring

Prior quarters

This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.